Norges Bank made a bold pharmaceutical play by investing $1.99 billion in Bristol-Myers Squibb, grabbing 1.73% of the company. Other institutional investors like Truist Financial, Inspire Trust, and ...

This was the stock's second consecutive day of gains.

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

Clayton's clients at S&C have included Barclays Bank, Goldman Sachs Group, Coinbase, Brevan Howard Asset Management and ...

Dividend investing appears to be a simple strategy on the surface, but in reality, it requires a much deeper analysis.

Halozyme Therapeutics (HALO) announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products ...

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...